![](/wp-content/uploads/2019/06/european-medicines-agency-announcement.png)
$599
Removal of Forxiga T1DM Indication? Generic Sitagliptin Up for Opinion?; July 19-22 CHMP Agenda
The CHMP agenda for this month (July 19-22) has been released, and it includes two notable items, Forxiga T1DM indication removal and generic sitagliptin, as well as several other cardiometabolic-related entries. Below, FENIX provides highlights and insights from the respective news items.